140 related articles for article (PubMed ID: 20175780)
1. Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity.
Hsu DS; Chang SY; Liu CJ; Tzeng CH; Wu KJ; Kao JY; Yang MH
Cancer Sci; 2010 Apr; 101(4):1029-37. PubMed ID: 20175780
[TBL] [Abstract][Full Text] [Related]
2. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
4. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
8. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.
Fang FM; Li CF; Huang HY; Lai MT; Chen CM; Chiu IW; Wang TL; Tsai FJ; Shih IeM; Sheu JJ
Am J Pathol; 2011 May; 178(5):2407-15. PubMed ID: 21514451
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of NBS1 and Snail expression in esophageal squamous cell carcinoma.
Kuo KT; Chou TY; Hsu HS; Chen WL; Wang LS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S549-57. PubMed ID: 21881923
[TBL] [Abstract][Full Text] [Related]
11. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
[TBL] [Abstract][Full Text] [Related]
12. Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients.
Clark C; Shah S; Herman-Ferdinandez L; Ekshyyan O; Abreo F; Rong X; McLarty J; Lurie A; Milligan EJ; Nathan CO
Laryngoscope; 2010 Jun; 120(6):1159-65. PubMed ID: 20513033
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer.
Yang MH; Chang SY; Chiou SH; Liu CJ; Chi CW; Chen PM; Teng SC; Wu KJ
Oncogene; 2007 Mar; 26(10):1459-67. PubMed ID: 16936774
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
17. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
18. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
20. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]